GB917012A - Reagent for the control of coagulability of blood - Google Patents
Reagent for the control of coagulability of bloodInfo
- Publication number
- GB917012A GB917012A GB10940/59A GB1094059A GB917012A GB 917012 A GB917012 A GB 917012A GB 10940/59 A GB10940/59 A GB 10940/59A GB 1094059 A GB1094059 A GB 1094059A GB 917012 A GB917012 A GB 917012A
- Authority
- GB
- United Kingdom
- Prior art keywords
- cephalin
- factor
- plasma
- reagent
- bovine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003153 chemical reaction reagent Substances 0.000 title abstract 5
- 210000004369 blood Anatomy 0.000 title abstract 3
- 239000008280 blood Substances 0.000 title abstract 3
- 210000002381 plasma Anatomy 0.000 abstract 8
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 abstract 6
- 241000283690 Bos taurus Species 0.000 abstract 6
- PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 abstract 4
- 102100023804 Coagulation factor VII Human genes 0.000 abstract 4
- 108010023321 Factor VII Proteins 0.000 abstract 4
- 108010094028 Prothrombin Proteins 0.000 abstract 4
- 102100027378 Prothrombin Human genes 0.000 abstract 4
- 108010000499 Thromboplastin Proteins 0.000 abstract 4
- 102000002262 Thromboplastin Human genes 0.000 abstract 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 abstract 4
- 210000004556 brain Anatomy 0.000 abstract 4
- 229940039716 prothrombin Drugs 0.000 abstract 4
- 238000012360 testing method Methods 0.000 abstract 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 abstract 2
- 102100029117 Coagulation factor X Human genes 0.000 abstract 2
- 102100030556 Coagulation factor XII Human genes 0.000 abstract 2
- 241000283073 Equus caballus Species 0.000 abstract 2
- 108010014173 Factor X Proteins 0.000 abstract 2
- 108010080865 Factor XII Proteins 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 abstract 2
- 241000282898 Sus scrofa Species 0.000 abstract 2
- 239000007853 buffer solution Substances 0.000 abstract 2
- 229910001628 calcium chloride Inorganic materials 0.000 abstract 2
- 239000001110 calcium chloride Substances 0.000 abstract 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 230000015271 coagulation Effects 0.000 abstract 2
- 238000005345 coagulation Methods 0.000 abstract 2
- 238000000502 dialysis Methods 0.000 abstract 2
- 229940067606 lecithin Drugs 0.000 abstract 2
- 235000010445 lecithin Nutrition 0.000 abstract 2
- 239000000787 lecithin Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- 239000011575 calcium Substances 0.000 abstract 1
- 150000002500 ions Chemical class 0.000 abstract 1
- 229910001427 strontium ion Inorganic materials 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2496/00—Reference solutions for assays of biological material
- G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO12810458 | 1958-05-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB917012A true GB917012A (en) | 1963-01-30 |
Family
ID=19908436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB10940/59A Expired GB917012A (en) | 1958-05-16 | 1959-03-31 | Reagent for the control of coagulability of blood |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3179567A (enrdf_load_stackoverflow) |
| CH (1) | CH408283A (enrdf_load_stackoverflow) |
| DE (1) | DE1189763B (enrdf_load_stackoverflow) |
| ES (1) | ES249137A1 (enrdf_load_stackoverflow) |
| FR (1) | FR1223856A (enrdf_load_stackoverflow) |
| GB (1) | GB917012A (enrdf_load_stackoverflow) |
| NL (2) | NL123584C (enrdf_load_stackoverflow) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0158254A1 (de) * | 1984-04-09 | 1985-10-16 | BEHRINGWERKE Aktiengesellschaft | Reagenz zur Bestimmung der Thromboplastinzeit |
| US11604026B2 (en) | 2019-03-14 | 2023-03-14 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
| US11634257B2 (en) | 2017-10-09 | 2023-04-25 | Terumo Bct Biotechnologies, Llc | Lyophilization container and method of using same |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3293134A (en) * | 1961-09-08 | 1966-12-20 | Warner Lambert Pharmaceutical | Diagnostic reagent composition for determining blood coagulation factors and method of use |
| US3395210A (en) * | 1964-02-07 | 1968-07-30 | Warner Lambert Pharmaceutical | Lyophilized diagnostic reagent for the determination of blood coagulation factors |
| US3486981A (en) * | 1965-03-15 | 1969-12-30 | Roy E Speck | Substances relating to testing of blood-coagulation |
| US3228841A (en) * | 1965-06-10 | 1966-01-11 | Warner Lambert Pharmaceutical | Diagnostic reagent composition for determining blood coagulation factors and method of use |
| US3880714A (en) * | 1973-07-18 | 1975-04-29 | Warner Lambert Co | Diagnostic reagent |
| US3947378A (en) * | 1974-12-23 | 1976-03-30 | Warner-Lambert Company | Adsorbed plasma |
| US4002739A (en) * | 1975-02-18 | 1977-01-11 | Warner-Lambert Company | Soluble collagen |
| US4038147A (en) * | 1976-06-15 | 1977-07-26 | Becton, Dickinson And Company | Method for detecting endotoxins |
| DE2915310A1 (de) * | 1979-04-14 | 1980-10-30 | Behringwerke Ag | Neues partielles thromboplastin und dessen verwendung |
| DE3150596A1 (de) * | 1981-12-21 | 1983-06-30 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur herstellung von gewebsthromboplastin |
| DE3407280A1 (de) * | 1984-02-28 | 1985-09-19 | Gödecke AG, 1000 Berlin | Testsatz zur bestimmung der aktivierten partiellen thromboplastinzeit (ptt) mit erhoehter heparinempfindlichkeit |
| US4946775A (en) * | 1985-09-05 | 1990-08-07 | Yin E Thye | Composition, kit and method for assaying heparin and a method for making the composition |
| US4948724A (en) * | 1985-09-05 | 1990-08-14 | Yin E Thye | Composition, kit and method for assaying heparin and a method for making the composition |
| US4851336A (en) * | 1985-09-05 | 1989-07-25 | Yin E Thye | Composition, kit, and method for assaying heparinano a method for making the composition |
| US4755461A (en) * | 1986-04-17 | 1988-07-05 | Bio/Data Corporation | Tableted blood plasma microconcentrated thromboplastin coagulation reagent |
| AU744287B2 (en) * | 1990-11-13 | 2002-02-21 | Corvas International, Inc. | Tissue factor based prothrombin time reagent |
| US5314695A (en) * | 1990-11-13 | 1994-05-24 | Corvas International, Inc. | Tissue factor based prothrombin time reagent |
| US6203816B1 (en) * | 1990-11-13 | 2001-03-20 | Corvas International, Inc. | Tissue factor based prothrombin time reagent |
| US6248353B1 (en) | 1999-12-10 | 2001-06-19 | Dade Behring Inc. | Reconstitution of purified membrane proteins into preformed liposomes |
| US6596543B2 (en) | 2001-03-22 | 2003-07-22 | Dade Behring Inc. | Use of liposomes of defined composition and size for the preparation of prothrombin time reagents |
| IS2809B (is) * | 2011-03-08 | 2012-10-15 | Haskoli Islands | Blóðstorkumæling |
| CN112481355B (zh) * | 2020-11-16 | 2023-05-30 | 武汉市长立生物技术有限责任公司 | 液体型凝血酶原时间测定试剂盒及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2687980A (en) * | 1948-09-15 | 1954-08-31 | Ernest W Blanchard | Thromboplastin product and method for preparing same |
| US2847350A (en) * | 1954-05-27 | 1958-08-12 | Ortho Pharma Corp | Preparation of highly active thromboplastin |
-
0
- NL NL238873D patent/NL238873A/xx unknown
- NL NL123584D patent/NL123584C/xx active
-
1959
- 1959-03-31 GB GB10940/59A patent/GB917012A/en not_active Expired
- 1959-04-30 DE DEO6747A patent/DE1189763B/de active Pending
- 1959-05-02 ES ES0249137A patent/ES249137A1/es not_active Expired
- 1959-05-04 CH CH7286559A patent/CH408283A/de unknown
- 1959-05-05 FR FR794205A patent/FR1223856A/fr not_active Expired
- 1959-05-12 US US812682A patent/US3179567A/en not_active Expired - Lifetime
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0158254A1 (de) * | 1984-04-09 | 1985-10-16 | BEHRINGWERKE Aktiengesellschaft | Reagenz zur Bestimmung der Thromboplastinzeit |
| US4784944A (en) * | 1984-04-09 | 1988-11-15 | Behringwerke Aktiengesellschaft | Prothrombin time determining reagent and methods of using and preparing the same |
| US11634257B2 (en) | 2017-10-09 | 2023-04-25 | Terumo Bct Biotechnologies, Llc | Lyophilization container and method of using same |
| US11604026B2 (en) | 2019-03-14 | 2023-03-14 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
| US11609042B2 (en) | 2019-03-14 | 2023-03-21 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
| US11609043B2 (en) | 2019-03-14 | 2023-03-21 | Terumo Bct Biotechnologies, Llc | Lyophilization container fill fixture, system and method of use |
| US11740019B2 (en) | 2019-03-14 | 2023-08-29 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
| US11747082B2 (en) | 2019-03-14 | 2023-09-05 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
| US11815311B2 (en) | 2019-03-14 | 2023-11-14 | Terumo Bct Biotechnologies, Llc | Lyophilization container fill fixture, system and method of use |
| US11994343B2 (en) | 2019-03-14 | 2024-05-28 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
Also Published As
| Publication number | Publication date |
|---|---|
| CH408283A (de) | 1966-02-28 |
| NL238873A (enrdf_load_stackoverflow) | |
| US3179567A (en) | 1965-04-20 |
| FR1223856A (fr) | 1960-06-21 |
| ES249137A1 (es) | 1959-11-16 |
| DE1189763B (de) | 1965-03-25 |
| NL123584C (enrdf_load_stackoverflow) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB917012A (en) | Reagent for the control of coagulability of blood | |
| Owen et al. | Prothrombin conversion factor of dicumarol plasma. | |
| Stefanini | Mechanism of blood coagulation in normal and pathologic conditions | |
| JP3055933B2 (ja) | 改良された安定な凝固対照 | |
| DE3587941D1 (de) | Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen. | |
| Hawkins et al. | Studies on cholinesterase. 6. The selective inhibition of true cholinesterase in vivo | |
| JPS56106594A (en) | Stabilizing method of plasminogen | |
| Booth | Carbonic anhydrase activity inside corpuscles. Enzyme-substrate accessibility factors | |
| McIlwain et al. | Induced loss in cerebral tissues of respiratory response to electrical impulses, and its partial restoration by additional substrates | |
| Spaet et al. | Inactivation of thromboplastin in human blood | |
| DOERR et al. | New evidence for intrinsic blood coagulation in chickens | |
| Gotterer et al. | Some factors which influence vesiculase action | |
| Mellanby et al. | Calcium and blood coagulation | |
| Fujimoto | Studies on the antitrypsin of serum | |
| Wadhwa et al. | The absorption of calcium ions from the ovine reticulo-rumen | |
| McClaughry et al. | Nature of an accelerator of prothrombin activation arising during storage of purified prothrombin. | |
| DE3850728D1 (de) | Methode zur Bestimmung des Verhaltens von Medikamenten in Lebewesen. | |
| Kawada et al. | An appropriate model for congenital hypothyroidism in the rat induced by neonatal treatment with propylthiouracil and surgical thyroidectomy: studies on learning ability and biochemical parameters | |
| GB1003748A (en) | Diagnostic compositions for the determination of blood coagulant factor levels | |
| ATE73673T1 (de) | Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung. | |
| US3993585A (en) | Elevated human lipids control | |
| US5021243A (en) | Process for the preparation of factor VIII:C-deficient plasma, and a deficient plasma obtained in this way | |
| Mellanby et al. | The carbon dioxide carrying power of the constituents of plasma. The alkali reserve of blood | |
| GB906860A (en) | Improvements relating to blood coagulation test reagents | |
| Smith et al. | Lung extract and blood clotting |